Investment Analysts’ Price Target Changes for September 1st (AAPL, AMAT, AON, ASMB, BMRN, CALY, CPT, CRDA, EROK, HIW)

Investment Analysts’ price target changes for Tuesday, September 1st:

Apple (NASDAQ:AAPL) had its target price increased by Rosenblatt Securities from $300.00 to $303.00. Rosenblatt Securities currently has a neutral rating on the stock.

Applied Materials (NASDAQ:AMAT) had its price target raised by UBS Group AG from $675.00 to $695.00. The firm currently has a buy rating on the stock.

AON (NYSE:AON) had its target price cut by Cantor Fitzgerald from $445.00 to $433.00. Cantor Fitzgerald currently has an overweight rating on the stock.

AON (NYSE:AON) had its target price lowered by Mizuho from $437.00 to $398.00. They currently have an outperform rating on the stock.

Assembly Biosciences (NASDAQ:ASMB) had its target price reduced by Mizuho from $53.00 to $45.00. Mizuho currently has an outperform rating on the stock.

BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target boosted by Piper Sandler from $88.00 to $90.00. The firm currently has an overweight rating on the stock.

Topgolf Callaway Brands (NYSE:CALY) had its price target raised by Truist Financial Corporation from $19.00 to $20.00. Truist Financial Corporation currently has a buy rating on the stock.

Camden Property Trust (NYSE:CPT) had its target price trimmed by Wells Fargo & Company from $113.00 to $110.00. They currently have an equal weight rating on the stock.

Croda International (LON:CRDA) had its target price increased by Jefferies Financial Group Inc. from GBX 3,500 to GBX 4,000. Jefferies Financial Group Inc. currently has a buy rating on the stock.

EagleRock Land (NYSE:EROK) had its target price raised by Piper Sandler from $28.00 to $33.00. Piper Sandler currently has an overweight rating on the stock.

Highwoods Properties (NYSE:HIW) had its price target raised by Wells Fargo & Company from $26.00 to $32.00. The firm currently has an equal weight rating on the stock.

Kayne Anderson BDC (NYSE:KBDC) had its target price trimmed by UBS Group AG from $15.00 to $13.50. They currently have a neutral rating on the stock.

KLA (NASDAQ:KLAC) had its target price trimmed by UBS Group AG from $215.00 to $200.00. UBS Group AG currently has a neutral rating on the stock.

Kilroy Realty (NYSE:KRC) had its price target increased by Wells Fargo & Company from $33.00 to $38.00. Wells Fargo & Company currently has an equal weight rating on the stock.

Novogen (NASDAQ:KZIA) had its price target raised by BTIG Research from $34.00 to $40.00. They currently have a buy rating on the stock.

Lam Research (NASDAQ:LRCX) had its target price trimmed by UBS Group AG from $435.00 to $425.00. They currently have a buy rating on the stock.

Mid-America Apartment Communities (NYSE:MAA) had its target price lowered by Wells Fargo & Company from $148.00 to $146.00. They currently have an overweight rating on the stock.

Medtronic (NYSE:MDT) had its target price increased by BTIG Research from $91.00 to $100.00. BTIG Research currently has a buy rating on the stock.

MiniMed Group (NASDAQ:MMED) had its target price increased by BTIG Research from $25.00 to $28.00. The firm currently has a buy rating on the stock.

Morgan Stanley Direct Lending Fund (NYSE:MSDL) had its price target reduced by UBS Group AG from $16.25 to $15.50. They currently have a neutral rating on the stock.

MSC Income Fund (NYSE:MSIF) had its price target cut by UBS Group AG from $13.50 to $12.50. The firm currently has a neutral rating on the stock.

ODDITY Tech (NASDAQ:ODD) had its target price raised by Truist Financial Corporation from $12.00 to $16.00. The firm currently has a hold rating on the stock.

Omega Healthcare Investors (NYSE:OHI) had its price target trimmed by Wells Fargo & Company from $49.00 to $48.00. They currently have an equal weight rating on the stock.

ONEOK (NYSE:OKE) had its target price boosted by JPMorgan Chase & Co. from $95.00 to $106.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Oracle (NYSE:ORCL) had its target price cut by TD Cowen from $300.00 to $240.00. They currently have a buy rating on the stock.

Postal Realty Trust (NYSE:PSTL) had its price target increased by Scotiabank from $25.00 to $26.00. They currently have a sector outperform rating on the stock.

Protagonist Therapeutics (NASDAQ:PTGX) had its price target increased by BMO Capital Markets from $178.00 to $190.00. The firm currently has an outperform rating on the stock.

Raymond James Financial (NYSE:RJF) had its target price reduced by TD Cowen from $161.00 to $160.00. The firm currently has a hold rating on the stock.

Reckitt Benckiser Group (LON:RKT) had its target price raised by JPMorgan Chase & Co. from GBX 5,800 to GBX 6,500. They currently have an overweight rating on the stock.

Science Applications International (NASDAQ:SAIC) had its price target boosted by UBS Group AG from $108.00 to $123.00. The firm currently has a neutral rating on the stock.

Science Applications International (NASDAQ:SAIC) had its target price increased by Truist Financial Corporation from $110.00 to $130.00. They currently have a hold rating on the stock.

SailPoint (NASDAQ:SAIL) had its target price increased by Cantor Fitzgerald from $23.00 to $25.00. The firm currently has an overweight rating on the stock.

Snowflake (NYSE:SNOW) had its price target raised by Rosenblatt Securities from $285.00 to $345.00. The firm currently has a buy rating on the stock.

USA Compression Partners (NYSE:USAC) had its price target increased by Royal Bank Of Canada from $30.00 to $31.00. They currently have a sector perform rating on the stock.

Valero Energy (NYSE:VLO) had its price target raised by Wells Fargo & Company from $356.00 to $389.00. The firm currently has an overweight rating on the stock.

VeriSign (NASDAQ:VRSN) had its target price increased by Wedbush from $324.00 to $341.00. Wedbush currently has an outperform rating on the stock.

Workiva (NYSE:WK) had its target price raised by Robert W. Baird from $74.00 to $95.00. The firm currently has an outperform rating on the stock.